Japanese Government Procurement

National University Corporation - Notice of Procurement (Goods & Services)A Polatuzumab Vedotin (Genetical Recombination) (30㎎/vial) 652 vials,Ｂ　Eculizumab (Genetical Recombination) (300㎎30ml／vial) 234 vials,Ｃ　Nusinersen Sodium (12㎎5ml／vial) 6 vials,Ｄ　Faricimab (Genetical Recombination) (0.24ml／vial) 250 vials,Ｅ　Onasemnogene abeparvovec (1 case) 1 Set

This procurement is covered by the WTO Agreement on Government Procurement, Japan-EU Economic Partnership Agreement or Japan-UK Comprehensive Economic Partnership Agreement.

Japanese

Publishing date Jan 26, 2024
Type of notice Notice of Procurement (Goods & Services)
Procurement entity National University Corporation - Yamanashi
Classification
0004 Medical & Pharmaceutical Products
Summay of notice ⑴ Official in charge of disbursement of the procuring entity : Nakamura Kazuhiko, President of University of Yamanashi
⑵ Classification of the products to be procured : 4
⑶ Nature and quantity of the products to be purchased :
A Polatuzumab Vedotin (Genetical Recombination) (30㎎/vial) 652 vials
B Eculizumab (Genetical Recombination) (300㎎30ml/vial) 234 vials
C Nusinersen Sodium (12㎎5ml/vial) 6 vials
D Faricimab (Genetical Recombination) (0.24ml/vial) 250 vials
E Onasemnogene abeparvovec (1 case) 1 Set
⑷ Delivery period : From 1 April, 2024 through 31 March, 2025
⑸ Delivery place : University of Yamanashi Hospital
⑹ Qualifications for participating in the tendering procedures : Suppliers eligible for participating in the proposed tender are those who shall :
A not come under Article 2 and 3 of the Regulation concerning the Contract for University of Yamanashi Furthermore, minors, Person under Conservatorship or Person under Assistance that obtained the consent necessary for concluding a contract may be applicable under cases of special reasons within the said clause,
B have the Grade A, Grade B or Grade C qualification during fiscal 2023 in the Kanto・Koshinetsu area in sales of product for participating in tenders by Single qualification for every ministry and agency,
C prove to have prepared a system to provide rapid after-sale service and maintenance for the procured products,
D prove to have the ability to deliver the products, required by this notice, on the date and to the place specified by the Obligating Officer,
E prove to have obtained license for selling a medical instrument in accordance with the Law on Securing Quality, Efficacy and Safety of Products including Pharmaceuticals and Medical Devices,
F meet the qualification requirements which President of University of Yama-nashi may specify in accordance with Article 4 of the Regulation,
G not be currently under a suspension of business order as instructed by President of University of Yamanashi.
⑺ Time limit of tender : 15 : 00 21 March, 2024
⑻ Contact point for the notice : Hatamochi Yamato, Faculty of Medicine Accounting Division University of Yamanashi, 1110 Simokato Chuo-City Yamanashi 409-3898 Japan, TEL 055-273-8255
⑼ Please be noted that if it is indicated that environmental conditions relating to the procurement are laid down in its tender documents.